SCN1A and channelopathy: The last decade has witnessed a tremendous growth in our understanding of the pathophysiology of SCN1A channelopathies, due in part to the identification of disease-causing variants with novel biophysical consequences, and the development of mouse models enabling the characterization of neuronal impairment across different cellular populations (44).